Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10017649HBVENSG00000110090.13protein_codingCPT1ANoNo1374P50416
Q8WZ48
TVIS30030581HIVENSG00000110090.13protein_codingCPT1ANoNo1374P50416
Q8WZ48
TVIS30030582HIVENSG00000110090.13protein_codingCPT1ANoNo1374P50416
Q8WZ48
TVIS30030583HIVENSG00000110090.13protein_codingCPT1ANoNo1374P50416
Q8WZ48
TVIS20037299HPVENSG00000110090.13protein_codingCPT1ANoNo1374P50416
Q8WZ48
TVIS20014150HPVENSG00000110090.13protein_codingCPT1ANoNo1374P50416
Q8WZ48
TVIS20032478HPVENSG00000110090.13protein_codingCPT1ANoNo1374P50416
Q8WZ48
TVIS44017386HTLV-1ENSG00000110090.13protein_codingCPT1ANoNo1374P50416
Q8WZ48
TVIS44046649HTLV-1ENSG00000110090.13protein_codingCPT1ANoNo1374P50416
Q8WZ48
TCGA Plot Options
Drug Information
GeneCPT1A
DrugBank IDDB01016
Drug NameGlyburide
Target IDBE0000406
UniProt IDP50416
Regulation Typeinhibitor
PubMed IDs3090894; 3104327
CitationsPatel TB: Effect of sulfonylureas on hepatic fatty acid oxidation. Am J Physiol. 1986 Aug;251(2 Pt 1):E241-6.@@Cook GA: The hypoglycemic sulfonylureas glyburide and tolbutamide inhibit fatty acid oxidation by inhibiting carnitine palmitoyltransferase. J Biol Chem. 1987 Apr 15;262(11):4968-72.
GroupsApproved
Direct ClassificationBenzenesulfonamides
SMILESCOC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
PathwaysGlibenclamide Action Pathway
PharmGKBPA449782
ChEMBLCHEMBL472